Martine Rothblatt

United Therapeutics

Chairman and Chief Executive Officer

Overview

Martine Rothblatt made an average of $17.4M in compensation at United Therapeutics from 2006 to 2018.

Annual data

2018

In 2018, Martine Rothblatt earned a total compensation of $16M as Chairman and Chief Executive Officer at United Therapeutics.

Ranking235 out of 10,923
Percentile97.8%

Martine Rothblatt's 2018 compensation ranked 235th out of 10,923 executive pay records tracked by us this year.

Rothblatt earned more than 97.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking25 out of 1,243
Percentile98.0%

In the industry group of Drugs, Rothblatt's pay ranked 25th out of 1,243 executive pay records tracked by us in 2018.

Rothblatt earned more than 98.0% of executives in this group.

Non-Equity Incentive Plan$2,021,250
Option Awards$12,796,803
Salary$1,208,447
Other$9,800
Total$16,036,300

Rothblatt received $12.8M in option awards, which accounts for 79.80% of total compensation.

Rothblatt also received $2M in non-equity incentive plan, $1.2M in salary and $9.8K in other compensation.

2017

In 2017, Martine Rothblatt earned a total compensation of $37.1M as Chairman and Chief Executive Officer at United Therapeutics.

Ranking42 out of 13,772
Percentile99.7%

Martine Rothblatt's 2017 compensation ranked 42nd out of 13,772 executive pay records tracked by us this year.

Rothblatt earned more than 99.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking2 out of 1,566
Percentile99.9%

In the industry group of Drugs, Rothblatt's pay ranked 2nd out of 1,566 executive pay records tracked by us in 2017.

Rothblatt earned more than 99.9% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,239,653
Non-Equity Incentive Plan$1,598,163
Option Awards$33,122,078
Salary$1,163,707
Other$9,600
Total$37,133,201

Rothblatt received $33.1M in option awards, which accounts for 89.20% of total compensation.

Rothblatt also received $1.2M of change in pension value and nonqualified deferred compensation earnings, $1.6M in non-equity incentive plan, $1.2M in salary and $9.6K in other compensation.

2016

In 2016, Martine Rothblatt earned a total compensation of $15.4M as Chairman and Chief Executive Officer at United Therapeutics.

Ranking224 out of 14,038
Percentile98.4%

Martine Rothblatt's 2016 compensation ranked 224th out of 14,038 executive pay records tracked by us this year.

Rothblatt earned more than 98.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking16 out of 1,500
Percentile98.9%

In the industry group of Drugs, Rothblatt's pay ranked 16th out of 1,500 executive pay records tracked by us in 2016.

Rothblatt earned more than 98.9% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$611,425
Non-Equity Incentive Plan$992,464
Option Awards$12,583,891
Salary$1,226,949
Other$9,600
Total$15,424,329

Rothblatt received $12.6M in option awards, which accounts for 81.58% of total compensation.

Rothblatt also received $611.4K of change in pension value and nonqualified deferred compensation earnings, $992.5K in non-equity incentive plan, $1.2M in salary and $9.6K in other compensation.

2015

In 2015, Martine Rothblatt earned a total compensation of $2.3M as Chairman and Chief Executive Officer at United Therapeutics.

Ranking4,242 out of 13,586
Percentile68.8%

Martine Rothblatt's 2015 compensation ranked 4,242nd out of 13,586 executive pay records tracked by us this year.

Rothblatt earned more than 68.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking438 out of 1,485
Percentile70.5%

In the industry group of Drugs, Rothblatt's pay ranked 438th out of 1,485 executive pay records tracked by us in 2015.

Rothblatt earned more than 70.5% of executives in this group.

Non-Equity Incentive Plan$1,171,152
Salary$1,078,099
Other$18,626
Total$2,267,877

Rothblatt received $1.2M in non-equity incentive plan, which accounts for 51.64% of total compensation.

Rothblatt also received $1.1M in salary and $18.6K in other compensation.

2014

In 2014, Martine Rothblatt earned a total compensation of $33.2M as Chairman and Chief Executive Officer at United Therapeutics.

Ranking40 out of 12,932
Percentile99.7%

Martine Rothblatt's 2014 compensation ranked 40th out of 12,932 executive pay records tracked by us this year.

Rothblatt earned more than 99.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking7 out of 1,316
Percentile99.5%

In the industry group of Drugs, Rothblatt's pay ranked 7th out of 1,316 executive pay records tracked by us in 2014.

Rothblatt earned more than 99.5% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,633,033
Non-Equity Incentive Plan$1,073,981
Option Awards$29,460,128
Salary$1,024,524
Other$23,263
Total$33,214,929

Rothblatt received $29.5M in option awards, which accounts for 88.70% of total compensation.

Rothblatt also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $1.1M in non-equity incentive plan, $1M in salary and $23.3K in other compensation.

2013

In 2013, Martine Rothblatt earned a total compensation of $38.2M as Chairman and Co-Chief Executive Officer at United Therapeutics.

Ranking20 out of 12,071
Percentile99.8%

Martine Rothblatt's 2013 compensation ranked 20th out of 12,071 executive pay records tracked by us this year.

Rothblatt earned more than 99.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1 out of 1,102
Percentile99.9%

In the industry group of Drugs, Rothblatt's pay ranked 1st out of 1,102 executive pay records tracked by us in 2013.

Rothblatt earned more than 99.9% of executives in this group.

Non-Equity Incentive Plan$1,102,907
Option Awards$36,097,326
Salary$992,678
Other$25,344
Total$38,218,255

Rothblatt received $36.1M in option awards, which accounts for 94.45% of total compensation.

Rothblatt also received $1.1M in non-equity incentive plan, $992.7K in salary and $25.3K in other compensation.

2012

In 2012, Martine Rothblatt earned a total compensation of $8M as Chairman and Co, Chief Executive Officer at United Therapeutics.

Ranking610 out of 11,145
Percentile94.5%

Martine Rothblatt's 2012 compensation ranked 610th out of 11,145 executive pay records tracked by us this year.

Rothblatt earned more than 94.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking26 out of 863
Percentile97.0%

In the industry group of Drugs, Rothblatt's pay ranked 26th out of 863 executive pay records tracked by us in 2012.

Rothblatt earned more than 97.0% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$2,964,410
Non-Equity Incentive Plan$983,362
Option Awards$3,024,662
Salary$959,579
Other$26,315
Total$7,958,328

Rothblatt received $3M in option awards, which accounts for 38.01% of total compensation.

Rothblatt also received $3M of change in pension value and nonqualified deferred compensation earnings, $983.4K in non-equity incentive plan, $959.6K in salary and $26.3K in other compensation.

2011

In 2011, Martine Rothblatt earned a total compensation of $3.2M as Chief Executive Officer at United Therapeutics.

Ranking1,961 out of 10,255
Percentile80.9%

Martine Rothblatt's 2011 compensation ranked 1,961st out of 10,255 executive pay records tracked by us this year.

Rothblatt earned more than 80.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking87 out of 716
Percentile87.8%

In the industry group of Drugs, Rothblatt's pay ranked 87th out of 716 executive pay records tracked by us in 2011.

Rothblatt earned more than 87.8% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,409,730
Non-Equity Incentive Plan$804,960
Salary$931,485
Other$15,175
Total$3,161,350

Rothblatt received $1.4M of change in pension value and nonqualified deferred compensation earnings, which accounts for 44.59% of total compensation.

Rothblatt also received $805K in non-equity incentive plan, $931.5K in salary and $15.2K in other compensation.

2010

In 2010, Martine Rothblatt earned a total compensation of $17.6M as Chief Executive Officer at United Therapeutics.

Ranking104 out of 9,769
Percentile98.9%

Martine Rothblatt's 2010 compensation ranked 104th out of 9,769 executive pay records tracked by us this year.

Rothblatt earned more than 98.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking5 out of 636
Percentile99.2%

In the industry group of Drugs, Rothblatt's pay ranked 5th out of 636 executive pay records tracked by us in 2010.

Rothblatt earned more than 99.2% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,526,156
Non-Equity Incentive Plan$900,000
Option Awards$14,263,681
Salary$874,768
Other$56,203
Total$17,620,808

Rothblatt received $14.3M in option awards, which accounts for 80.95% of total compensation.

Rothblatt also received $1.5M of change in pension value and nonqualified deferred compensation earnings, $900K in non-equity incentive plan, $874.8K in salary and $56.2K in other compensation.

2009

In 2009, Martine Rothblatt earned a total compensation of $17.6M as Chief Executive Officer at United Therapeutics.

Ranking71 out of 9,043
Percentile99.2%

Martine Rothblatt's 2009 compensation ranked 71st out of 9,043 executive pay records tracked by us this year.

Rothblatt earned more than 99.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking10 out of 593
Percentile98.3%

In the industry group of Drugs, Rothblatt's pay ranked 10th out of 593 executive pay records tracked by us in 2009.

Rothblatt earned more than 98.3% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,755,503
Non-Equity Incentive Plan$440,125
Option Awards$14,577,981
Salary$798,203
Other$19,286
Total$17,591,098

Rothblatt received $14.6M in option awards, which accounts for 82.87% of total compensation.

Rothblatt also received $1.8M of change in pension value and nonqualified deferred compensation earnings, $440.1K in non-equity incentive plan, $798.2K in salary and $19.3K in other compensation.

2008

In 2008, Martine Rothblatt earned a total compensation of $5.6M as Chief Executive Officer at United Therapeutics.

Ranking640 out of 8,143
Percentile92.1%

Martine Rothblatt's 2008 compensation ranked 640th out of 8,143 executive pay records tracked by us this year.

Rothblatt earned more than 92.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking29 out of 552
Percentile94.7%

In the industry group of Drugs, Rothblatt's pay ranked 29th out of 552 executive pay records tracked by us in 2008.

Rothblatt earned more than 94.7% of executives in this group.

Bonus$22,500
Change in Pension Value and Nonqualified Deferred Compensation Earnings$671,061
Non-Equity Incentive Plan$633,750
Option Awards$3,425,729
Salary$796,304
Other$15,930
Total$5,565,274

Rothblatt received $3.4M in option awards, which accounts for 61.56% of total compensation.

Rothblatt also received $22.5K in bonus, $671.1K of change in pension value and nonqualified deferred compensation earnings, $633.8K in non-equity incentive plan, $796.3K in salary and $15.9K in other compensation.

2007

In 2007, Martine Rothblatt earned a total compensation of $25.3M as Chief Executive Officer at United Therapeutics.

Ranking47 out of 7,436
Percentile99.4%

Martine Rothblatt's 2007 compensation ranked 47th out of 7,436 executive pay records tracked by us this year.

Rothblatt earned more than 99.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking4 out of 486
Percentile99.2%

In the industry group of Drugs, Rothblatt's pay ranked 4th out of 486 executive pay records tracked by us in 2007.

Rothblatt earned more than 99.2% of executives in this group.

Bonus$12,000
Change in Pension Value and Nonqualified Deferred Compensation Earnings$227,963
Non-Equity Incentive Plan$588,000
Option Awards$23,727,656
Salary$767,140
Other$19,840
Total$25,342,599

Rothblatt received $23.7M in option awards, which accounts for 93.63% of total compensation.

Rothblatt also received $12K in bonus, $228K of change in pension value and nonqualified deferred compensation earnings, $588K in non-equity incentive plan, $767.1K in salary and $19.8K in other compensation.

2006

In 2006, Martine Rothblatt earned a total compensation of $6.2M as Chief Executive Officer at United Therapeutics.

Ranking395 out of 5,851
Percentile93.2%

Martine Rothblatt's 2006 compensation ranked 395th out of 5,851 executive pay records tracked by us this year.

Rothblatt earned more than 93.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking15 out of 445
Percentile96.6%

In the industry group of Drugs, Rothblatt's pay ranked 15th out of 445 executive pay records tracked by us in 2006.

Rothblatt earned more than 96.6% of executives in this group.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$5,204,200
Non-Equity Incentive Plan$300,000
Salary$725,000
Other$9,500
Total$6,238,700

Rothblatt received $5.2M of change in pension value and nonqualified deferred compensation earnings, which accounts for 83.42% of total compensation.

Rothblatt also received $300K in non-equity incentive plan, $725K in salary and $9.5K in other compensation.